(Q43605407)

English

Neutralization of HPV16, 18, 31, and 58 pseudovirions with antisera induced by immunizing rabbits with synthetic peptides representing segments of the HPV16 minor capsid protein L2 surface region

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Neutralization of HPV16, 18, 31, and 58 pseudovirions with antisera induced by immunizing rabbits with synthetic peptides representing segments of the HPV16 minor capsid protein L2 surface region (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

0 references

Hiroyuki Yoshikawa

5

object named as

Hiroyuki Yoshikawa

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

author name string

Kazunari Kondo

1

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Yoshiyuki Ishii

2

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Hiroyuki Ochi

3

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Tamae Matsumoto

4

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Tadahito Kanda

6

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

language of work or name

0 references

publication date

28 September 2006

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

number of pages

7

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

358

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

266-272

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

describes a project that uses

synthetic peptide

1 reference

based on heuristic

inferred from title

Structures of bovine and human papillomaviruses. Analysis by cryoelectron microscopy and three-dimensional image reconstruction

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.037

7 January 2021

Efficient intracellular assembly of papillomaviral vectors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.037

7 January 2021

A COMPARATIVE STUDY OF POLYOMA AND PAPILLOMA VIRUSES

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.037

7 January 2021

Protective immunity to rabbit oral and cutaneous papillomaviruses by immunization with short peptides of L2, the minor capsid protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.037

7 January 2021

Immunological analyses of human papillomavirus capsids

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.037

7 January 2021

Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.037

7 January 2021

Human papillomavirus type 16 capsids expose multiple type-restricted and type-common antigenic epitopes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.037

7 January 2021

Cancer in the developing world: a call to action.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.037

7 January 2021

Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.037

7 January 2021

Sequence close to the N-terminus of L2 protein is displayed on the surface of bovine papillomavirus type 1 virions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.037

7 January 2021

Against which human papillomavirus types shall we vaccinate and screen? The international perspective

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.037

7 January 2021

Cross-neutralization of cutaneous and mucosal Papillomavirus types with anti-sera to the amino terminus of L2.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.037

7 January 2021

Minor capsid protein of human genital papillomaviruses contains subdominant, cross-neutralizing epitopes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.037

7 January 2021

Human papillomaviruses and cervical neoplasia: a model for carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.037

7 January 2021

Infectious human papillomavirus type 18 pseudovirions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.037

7 January 2021

Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.037

7 January 2021

Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.037

7 January 2021

DNA packaging by L1 and L2 capsid proteins of bovine papillomavirus type 1

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.037

7 January 2021

Expression of vaccinia recombinant HPV 16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.037

7 January 2021

Synthesis and assembly of infectious bovine papillomavirus particles in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.037

7 January 2021

Common neutralization epitope in minor capsid protein L2 of human papillomavirus types 16 and 6

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.037

7 January 2021

Immunization with viruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.037

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VIROL.2006.08.037

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43605407&oldid=2101855021"